FLSW vs. THNR ETF Comparison
Comparison of Franklin FTSE Switzerland ETF (FLSW) to Amplify Weight Loss Drug & Treatment ETF (THNR)
FLSW
Franklin FTSE Switzerland ETF
FLSW Description
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the FTSE Switzerland RIC Capped Index (the FTSE Switzerland Capped Index). Under normal market conditions, the fund invests at least 80% of its assets in the component securities of the FTSE Switzerland Capped Index and in depositary receipts representing such securities. The FTSE Switzerland Capped Index is based on the FTSE Switzerland Index and is designed to measure the performance of Swiss large- and mid-capitalization stocks. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$32.85
Average Daily Volume
5,901
3
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$23.43
Average Daily Volume
2,584
15
Performance
| Period | FLSW | THNR |
|---|---|---|
| 30 Days | -6.60% | -11.31% |
| 60 Days | -6.50% | -15.54% |
| 90 Days | -9.69% | -17.09% |
| 12 Months | 8.63% |
0 Overlapping Holdings
| Symbol | Grade | Weight in FLSW | Weight in THNR | Overlap |
|---|
FLSW: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords
Compare ETFs
